42 related articles for article (PubMed ID: 10323256)
1. Identification of an Intravenous Injectable NK1 Receptor Antagonist for Use in Traumatic Brain Injury.
Vink R; Nimmo A
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542509
[TBL] [Abstract][Full Text] [Related]
2. Effects of Electrical Stimulation of NAc Afferents on VP Neurons' Tonic Firing.
Clark M
Front Cell Neurosci; 2020; 14():599920. PubMed ID: 33328895
[TBL] [Abstract][Full Text] [Related]
3. Emerging targets for addiction neuropharmacology: From mechanisms to therapeutics.
Ubaldi M; Cannella N; Ciccocioppo R
Prog Brain Res; 2016; 224():251-84. PubMed ID: 26822362
[TBL] [Abstract][Full Text] [Related]
4. The pharmacology of neurokinin receptors in addiction: prospects for therapy.
Sandweiss AJ; Vanderah TW
Subst Abuse Rehabil; 2015; 6():93-102. PubMed ID: 26379454
[TBL] [Abstract][Full Text] [Related]
5. The ventral pallidum: Subregion-specific functional anatomy and roles in motivated behaviors.
Root DH; Melendez RI; Zaborszky L; Napier TC
Prog Neurobiol; 2015 Jul; 130():29-70. PubMed ID: 25857550
[TBL] [Abstract][Full Text] [Related]
6. Gut-brain peptides in corticostriatal-limbic circuitry and alcohol use disorders.
Vadnie CA; Park JH; Abdel Gawad N; Ho AM; Hinton DJ; Choi DS
Front Neurosci; 2014; 8():288. PubMed ID: 25278825
[TBL] [Abstract][Full Text] [Related]
7. Stress-related neuropeptides and addictive behaviors: beyond the usual suspects.
Schank JR; Ryabinin AE; Giardino WJ; Ciccocioppo R; Heilig M
Neuron; 2012 Oct; 76(1):192-208. PubMed ID: 23040815
[TBL] [Abstract][Full Text] [Related]
8. Neuronal pathways linking substance P to drug addiction and stress.
Commons KG
Brain Res; 2010 Feb; 1314():175-82. PubMed ID: 19913520
[TBL] [Abstract][Full Text] [Related]
9. Cocaine and amphetamine-regulated transcript-containing neurons in the nucleus accumbens project to the ventral pallidum in the rat and may inhibit cocaine-induced locomotion.
Hubert GW; Manvich DF; Kuhar MJ
Neuroscience; 2010 Jan; 165(1):179-87. PubMed ID: 19825396
[TBL] [Abstract][Full Text] [Related]
10. Deficits in substance P mRNA levels in the CeA are inversely associated with alcohol-motivated responding.
Yang AR; Yi HS; Mamczarz J; June HL; Hwang BH; June HL
Synapse; 2009 Nov; 63(11):972-81. PubMed ID: 19593822
[TBL] [Abstract][Full Text] [Related]
11. Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.
Herpfer I; Lieb K
CNS Drugs; 2005; 19(4):275-93. PubMed ID: 15813642
[TBL] [Abstract][Full Text] [Related]
12. The effects of substance P after central administration on the activity of the mesolimbic system of the rat brain as studied by microdialysis.
Nikolaev SV; Lebedev AA; Bychkov ER; Oblyapin AV; Dambinova SA; Shabanov PD
Neurosci Behav Physiol; 2004 Sep; 34(7):743-6. PubMed ID: 15526431
[TBL] [Abstract][Full Text] [Related]
13. Place aversion induced by microinjections of C-fragment of substance P into the dorsal periaqueductal gray of rats is mediated by tachykinin NK1 receptors.
De Araújo JE; Huston JP; Brandão ML
Peptides; 2001 Sep; 22(9):1447-52. PubMed ID: 11514027
[TBL] [Abstract][Full Text] [Related]
14. The neurokinin-1 receptor antagonist WIN51,708 attenuates the anxiolytic-like effects of ventralpallidal substance P injection.
Nikolaus S; Huston JP; Hasenöhrl RU
Neuroreport; 1999 Aug; 10(11):2293-6. PubMed ID: 10439451
[TBL] [Abstract][Full Text] [Related]
15. Opioid activity of sendide, a tachykinin NK1 receptor antagonist.
Sakurada T; Yuhki M; Inoue M; Sakurada C; Tan-No K; Ohba M; Kisara K; Sakurada S
Eur J Pharmacol; 1999 Mar; 369(3):261-6. PubMed ID: 10225361
[TBL] [Abstract][Full Text] [Related]
16. New insights into the antidepressant actions of substance P (NK1 receptor) antagonists.
Rupniak NM
Can J Physiol Pharmacol; 2002 May; 80(5):489-94. PubMed ID: 12056558
[TBL] [Abstract][Full Text] [Related]
17. Substance P: structure, function, and therapeutics.
Datar P; Srivastava S; Coutinho E; Govil G
Curr Top Med Chem; 2004; 4(1):75-103. PubMed ID: 14754378
[TBL] [Abstract][Full Text] [Related]
18. Reinforcing effects of neurokinin substance P in the ventral pallidum: mediation by the tachykinin NK1 receptor.
Nikolaus S; Huston JP; Hasenöhrl RU
Eur J Pharmacol; 1999 Apr; 370(2):93-9. PubMed ID: 10323256
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
